Anavex Life Sciences Corp. (AVXL) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Anavex Life Sciences Corp...

    NASDAQ: AVXL · Real-Time Price · USD
    8.66
    0.16 (1.88%)
    At close: Sep 26, 2025, 3:59 PM
    8.66
    0.00%
    After-hours: Sep 26, 2025, 06:47 PM EDT

    Anavex Life Sciences Balance Sheet Statement

    Financials in USD. Fiscal year is October - September.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
    Cash & Equivalents
    		 132.19M 151.02M 149.16M 152.11M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 n/a 3.36M 3.55B 16.36K
    Receivables
    		 2.45M 2.71M 3.19M 9.14M
    Inventory
    		 n/a n/a n/a 16.36K
    Other Current Assets
    		 931K 653K 162.00 -16.36K
    Total Current Assets
    		 135.57M 154.39M 152.7M 161.62M
    Property-Plant & Equipment
    		 n/a n/a n/a n/a
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 n/a 3.36M 3.55B 16.36K
    Total Assets
    		 135.57M 154.39M 152.7M 161.62M
    Account Payables
    		 9.63M 4.32M 3.82M 4.74M
    Deferred Revenue
    		 842K n/a 443.83K 443.83K
    Short-Term Debt
    		 n/a n/a n/a n/a
    Other Current Liabilities
    		 1.53M 6.85M -47 n/a
    Total Current Liabilities
    		 15.3M 12.53M 10.21M 10.8M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 4.83M n/a n/a -386
    Total Long-Term Liabilities
    		 4.83M 7.29M 4.27M -386
    Total Liabilities
    		 15.3M 12.53M 10.21M 10.8M
    Total Debt
    		 n/a n/a n/a n/a
    Book Value
    		 n/a n/a n/a n/a
    Book Value Per Share
    		 n/a n/a n/a n/a
    Common Stock
    		 85K 82K 77.94K 75.92K
    Retained Earnings
    		 -336.07M -293.07M -245.56M -197.59M
    Comprehensive Income
    		 n/a n/a n/a n/a
    Shareholders Equity
    		 120.26M 141.85M 142.49M 150.82M
    Total Investments
    		 n/a n/a n/a n/a

    Add to Watchlist